FULT Stock Analysis: Fulton Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 4.645m USD | 12M Return: 35.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 48.9M
EPS Trend: 96.3%
Qual. Beats: 6
Rev. Trend: 92.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fulton Financial Corporation (NASDAQ: FULT) is a U.S. bank holding company headquartered in Lancaster, Pennsylvania, founded in 1882. Through its subsidiary Fulton Bank, the company provides a full suite of retail and commercial banking services, including checking, savings, and certificate of deposit accounts, consumer loans (home equity, mortgage, auto, student, and personal), and commercial lending products such as commercial real estate, industrial, and construction loans, as well as equipment lease financing. It also offers letters of credit, cash management, wealth management (investment management, trust, brokerage, insurance, and advisory services), and life insurance products. Services are distributed through financial center locations, ATMs, telephone, mobile, and online banking channels.
As a mid-cap regional bank operating in the Financials sector, FULTs business model is typical of community-oriented regional lenders, which rely on net interest income from local deposit gathering and loan origination as their primary revenue driver, supplemented by fee-based services like wealth management and treasury solutions. Regional banks like FULT often serve small- and mid-sized businesses and consumers in defined geographic markets, distinguishing them from nationwide money-center banks and from purely digital challenger banks.
- Net interest margin compression pressures profitability
- Commercial real estate loan losses weigh on credit quality
- Mid-Atlantic loan demand offsets rising deposit costs
| Net Income: 396.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.46 > 1.0 |
| NWC/Revenue: -1.22k% < 20% (prev -1.16k%; Δ -54.86% < -1%) |
| CFO/TA 0.01 > 3% & CFO 418.5m > Net Income 396.6m |
| Net Debt (-3.73b) to EBITDA (536.4m): -6.96 < 3 |
| Current Ratio: 0.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (187.4m) vs 12m ago 1.94% < -2% |
| Gross Margin: 69.26% > 18% (prev 64.65%; Δ 4.62% > 0.5%) |
| Asset Turnover: 5.75% > 50% (prev 5.98%; Δ -0.23% > 0%) |
| Interest Coverage Ratio: 0.89 > 6 (EBIT TTM 492.7m / Interest Expense TTM 556.1m) |
| A: -0.67 (Total Current Assets 6.68b - Total Current Liabilities 30.0b) / Total Assets 34.6b |
| B: 0.06 (Retained Earnings 2.02b / Total Assets 34.6b) |
| C: 0.01 (EBIT TTM 492.7m / Avg Total Assets 33.3b) |
| D: 0.12 (Book Value of Equity 3.82b / Total Liabilities 30.7b) |
| Altman-Z'' = -4.00 = D |
| DSRI: 0.24 (Receivables 121.2m/500.6m, Revenue 1.92b/1.92b) |
| GMI: 0.93 (GM 64.65% / 69.26%) |
| AQI: 0.92 (AQ_t 0.80 / AQ_t-1 0.87) |
| SGI: 1.00 (Revenue 1.92b / 1.92b) |
| TATA: -0.00 (NI 396.6m - CFO 418.5m) / TA 34.6b) |
| Beneish M = -3.76 (Cap -4..+1) = AAA |
As of July 28, 2026, the stock is trading at USD 24.40 with a total of 1,614,539 shares traded. Over the past week, the price has changed by -0.57%, over one month by +1.84%, over three months by +12.20% and over the past year by +35.94%.
Current recommended Stop Loss: 23.20 (which is 4.9% or 2.2 ATR below the current price).
Fulton Financial has received a consensus analysts rating of 3.57. Therefore, it is recommended to hold FULT.
- StrongBuy: 2
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 24.7 | 1.3% |
P/E Trailing = 11.6077
P/E Forward = 10.1523
P/S = 3.5998
P/B = 1.4085
P/EG = 1.5402
Revenue TTM = 1.92b USD
EBIT TTM = 492.7m USD
EBITDA TTM = 536.4m USD
Long Term Debt = 618.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.71b USD (from shortTermDebt, last quarter)
Debt = 1.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.73b USD (calculated: Debt 1.71b - CCE 5.45b)
Enterprise Value = 910.8m USD (4.64b + Debt 1.71b - CCE 5.45b)
Interest Coverage Ratio = 0.89 (Ebit TTM 492.7m / Interest Expense TTM 556.1m)
EV/FCF = 2.34x (Enterprise Value 910.8m / FCF TTM 389.3m)
FCF Yield = 42.74% (FCF TTM 389.3m / Enterprise Value 910.8m)
FCF Margin = 20.33% (FCF TTM 389.3m / Revenue TTM 1.92b)
Net Margin = 20.71% (Net Income TTM 396.6m / Revenue TTM 1.92b)
Gross Margin = 69.26% ((Revenue TTM 1.92b - Cost of Revenue TTM 588.6m) / Revenue TTM)
Gross Margin QoQ = 70.68% (prev 68.66%)
Tobins Q-Ratio = 0.03 (Enterprise Value 910.8m / Total Assets 34.6b)
Interest Expense / Debt = 32.45% (Interest Expense 556.1m / Debt 1.71b)
Taxrate = 19.51% (96.1m / 492.7m)
NOPAT = 396.6m (EBIT 492.7m * (1 - 19.51%))
Current Ratio = 0.22 (Total Current Assets 6.68b / Total Current Liabilities 30.0b)
Debt / Equity = 0.45 (Debt 1.71b / totalStockholderEquity, last quarter 3.82b)
Debt / EBITDA = -6.96 (Net Debt -3.73b / EBITDA 536.4m)
Debt / FCF = -9.59 (Net Debt -3.73b / FCF TTM 389.3m)
Total Stockholder Equity = 3.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.19% (Net Income 396.6m / Total Assets 34.6b)
RoE = 11.15% (Net Income TTM 396.6m / Total Stockholder Equity 3.56b)
RoCE = 11.80% (EBIT 492.7m / Capital Employed (Equity 3.56b + L.T.Debt 618.6m))
RoIC = 6.39% (NOPAT 396.6m / Invested Capital 6.21b)
WACC = 14.02% (E(4.64b)/V(6.36b) * Re(9.55%) + D(1.71b)/V(6.36b) * Rd(32.45%) * (1-Tc(0.20)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 67.36 | Cagr: 5.95%
[DCF] Terminal Value 61.87% ; FCFF base≈319.3m ; Y1≈366.0m ; Y5≈538.7m
[DCF] Fair Price = 40.51 (EV 4.02b - Net Debt -3.73b = Equity 7.76b / Shares 191.5m; r=14.02% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.25 | EPS CAGR: 12.09% | SUE: 1.72 | # QB: 6
Revenue Correlation: 92.35 | Revenue CAGR: 11.63% | SUE: 0.78 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.56 | Chg30d=+0.52% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=2.22 | Chg30d=+1.17% | Revisions=-25% | GrowthEPS=+2.8% | GrowthRev=+8.6%
EPS next Year (2027-12-31): EPS=2.36 | Chg30d=-0.54% | Revisions=-25% | GrowthEPS=+6.2% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: -50% (up=0, down=3)